Literature DB >> 16857692

The four ages of Down syndrome.

Alan H Bittles1, Carol Bower, Rafat Hussain, Emma J Glasson.   

Abstract

BACKGROUND: Down syndrome (DS) affects approximately 1 per 650-1000 live births and is the most common known genetic cause of intellectual disability. A highly significant change in the survival of people with DS has occurred during the last two generations, with life expectancy estimates increasing from 12 to nearly 60 years of age. SUBJECTS AND METHODS: Detailed information on 1332 people in Western Australia with DS was abstracted from a specialist statewide database for the period 1953-2000 and electronically linked with three other state or national health and mortality data sources and the state Birth Defects Registry.
RESULTS: Over the last 25 years the percentage of women over 35 years giving birth increased from 4.8 to 18.6%, accompanied by an increase in the overall prevalence of DS from 1.1 to 2.9 per 1000 births. Four life stages of DS were identified: prenatal, childhood and early adulthood, adulthood, and senescence. Although pneumonia, or other types of respiratory infections, was the most common cause of death across the entire lifespan, ranging from 23% of deaths in adulthood to 40% in senescence, each life stage exhibited a particular profile of comorbidities. Congenital heart defects were common causes in childhood (13%) and adulthood (23%), whereas in senescence coronary artery disease (10%) and cardiac, renal, and respiratory failure (9%) were leading causes of mortality.
CONCLUSIONS: A major re-appraisal in attitudes towards DS is required to ensure that the medical and social needs of people with the disorder are adequately met across their entire lifespan. In particular, specific recognition of the comorbidities that can arise at different ages is needed, accompanied by the provision of appropriate levels of care and management.

Entities:  

Mesh:

Year:  2006        PMID: 16857692     DOI: 10.1093/eurpub/ckl103

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  97 in total

1.  Dementia diagnostic criteria in Down syndrome.

Authors:  Rory Sheehan; Amanda Sinai; Nick Bass; Pippa Blatchford; Ingrid Bohnen; Simon Bonell; Ken Courtenay; Angela Hassiotis; Therese Markar; Jane McCarthy; Kamalika Mukherji; Asim Naeem; Dimitrios Paschos; Natalia Perez-Achiaga; Vijaya Sharma; David Thomas; Zuzana Walker; Andre Strydom
Journal:  Int J Geriatr Psychiatry       Date:  2014-11-03       Impact factor: 3.485

2.  Down syndrome: national conference on patient registries, research databases, and biobanks.

Authors:  Mary Lou Oster-Granite; Melissa A Parisi; Leonard Abbeduto; Dorit S Berlin; Cathy Bodine; Dana Bynum; George Capone; Elaine Collier; Dan Hall; Lisa Kaeser; Petra Kaufmann; Jeffrey Krischer; Michelle Livingston; Linda L McCabe; Jill Pace; Karl Pfenninger; Sonja A Rasmussen; Roger H Reeves; Yaffa Rubinstein; Stephanie Sherman; Sharon F Terry; Michelle Sie Whitten; Stephen Williams; Edward R B McCabe; Yvonne T Maddox
Journal:  Mol Genet Metab       Date:  2011-07-13       Impact factor: 4.797

3.  Screening key genes associated with congenital heart defects in Down syndrome based on differential expression network.

Authors:  Shan Yu; Huani Yi; Zhimin Wang; Juan Dong
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

Review 4.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.

Authors:  Donna M Wilcock; Frederick A Schmitt; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2015-11-26

5.  Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome.

Authors:  Verónica Vidal; Susana García-Cerro; Paula Martínez; Andrea Corrales; Sara Lantigua; Rebeca Vidal; Noemí Rueda; Laurence Ozmen; Maria-Clemencia Hernández; Carmen Martínez-Cué
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

6.  An observational study of adults with Down syndrome eating independently.

Authors:  Christina H Smith; Yafen Teo; Sarah Simpson
Journal:  Dysphagia       Date:  2013-07-17       Impact factor: 3.438

7.  Increased P-wave and QT dispersions necessitate long-term follow-up evaluation of Down syndrome patients with congenitally normal hearts.

Authors:  Cem Karadeniz; Rahmi Ozdemir; Fikri Demir; Yılmaz Yozgat; Mehmet Küçük; Talia Oner; Utku Karaarslan; Timur Meşe; Nurettin Unal
Journal:  Pediatr Cardiol       Date:  2014-05-25       Impact factor: 1.655

8.  Single-Word Speech Intelligibility in Children and Adults With Down Syndrome.

Authors:  Alyssa Wild; Houri K Vorperian; Ray D Kent; Daniel M Bolt; Diane Austin
Journal:  Am J Speech Lang Pathol       Date:  2018-02-06       Impact factor: 2.408

9.  Prevalence of Sleep Disorders in Adults With Down Syndrome: A Comparative Study of Self-Reported, Actigraphic, and Polysomnographic Findings.

Authors:  Sandra Giménez; Laura Videla; Sergio Romero; Bessy Benejam; Susana Clos; Susana Fernández; Maribel Martínez; Maria Carmona-Iragui; Rosa M Antonijoan; Mercedes Mayos; Ana Fortuna; Patricia Peñacoba; Vicente Plaza; Ricardo S Osorio; Ram A Sharma; Ignasi Bardés; Anne-Sophie Rebillat; Alberto Lleó; Rafael Blesa; Sebastian Videla; Juan Fortea
Journal:  J Clin Sleep Med       Date:  2018-10-15       Impact factor: 4.062

10.  Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer's Disease.

Authors:  Alex M Helman; Morgan Siever; Katie L McCarty; Ira T Lott; Eric Doran; Erin L Abner; Frederick A Schmitt; Elizabeth Head
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.